S

Sleep Cycle AB (publ)
F:1CW

Watchlist Manager
Sleep Cycle AB (publ)
F:1CW
Watchlist
Price: 2.1 EUR -0.47% Market Closed
Market Cap: €42.6m

Wall St Price Targets

1CW Price Targets Summary
Sleep Cycle AB (publ)

Wall Street analysts forecast 1CW stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 1CW is 2.87 EUR with a low forecast of 2.42 EUR and a high forecast of 3.39 EUR.

Lowest Forecast
Price Target
2.42 EUR
15% Upside
Average Forecast
Price Target
2.87 EUR
37% Upside
Highest Forecast
Price Target
3.39 EUR
61% Upside
Sleep Cycle AB (publ) Competitors:
Price Targets
PECO
Phillips Edison & Co Inc
20% Upside
PETS
Petmed Express Inc
24% Upside
1415
Cowell e Holdings Inc
74% Upside
MZX
Masterflex SE
44% Upside

Revenue
Forecast

12% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
12% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 6 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 7%.

Gross Profit
Forecast

13% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
13% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Over the last 6 years, the compound annual growth rate for Gross Profit has been 13%. The projected CAGR for the next 3 years is 9%.

Operating Income
Forecast

6% / Year
Past Growth
-1% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
6% / Year
Past Growth
-1% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 6 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 3 years is -1%.

Pre-Tax Income
Forecast

4% / Year
Past Growth
-11% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss
4% / Year
Past Growth
-11% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Over the last 6 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 3 years is -11%.

Net Income
Forecast

4% / Year
Past Growth
-17% / Year
Estimated Growth
Estimates Accuracy
-15%
Average Miss
4% / Year
Past Growth
-17% / Year
Estimated Growth
Estimates Accuracy
-15%
Average Miss

Over the last 6 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 3 years is -17%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 1CW's stock price target?
Price Target
2.87 EUR

According to Wall Street analysts, the average 1-year price target for 1CW is 2.87 EUR with a low forecast of 2.42 EUR and a high forecast of 3.39 EUR.

What is the Revenue forecast for Sleep Cycle AB (publ)?
Projected CAGR
7%

Over the last 6 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 7%.

What is the Gross Profit forecast for Sleep Cycle AB (publ)?
Projected CAGR
9%

Over the last 6 years, the compound annual growth rate for Gross Profit has been 13%. The projected CAGR for the next 3 years is 9%.

What is the Operating Income forecast for Sleep Cycle AB (publ)?
Projected CAGR
-1%

Over the last 6 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 3 years is -1%.

What is the Pre-Tax Income forecast for Sleep Cycle AB (publ)?
Projected CAGR
-11%

Over the last 6 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 3 years is -11%.

What is the Net Income forecast for Sleep Cycle AB (publ)?
Projected CAGR
-17%

Over the last 6 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 3 years is -17%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett